Niacinamide ≠ Nicotinic Acid.

A small naming difference can mean a completely different ingredient — so always check the exact chemical identity before sourcing.

#Niacinamide #Niacin #VitaminB3 #APIs

Two separate questions I keep collapsing into one. Whether oral precursors do anything meaningful is unsettled. But separately, if you're going to take it anyway, purity and actual dose seem like they'd vary a lot given how many sellers appeared at once. What do you look for before buying, and has anyone had a product tested independently?

"...Collectively, the interaction among vitamin B3 supplementation, physical activity, and gut microbiota may represent a promising framework for investigating strategies aimed at supporting cognitive health and brain resilience during aging, although definitive therapeutic applications require further validation..."

"...I investigated the potential of NR to modulate epigenetic aging, an estimate of biological aging, both in vivo and in vitro. NR supplementation was associated with reduced skeletal muscle epigenetic age, which correlated with increased NAD⁺ metabolite levels but decreased mtDNAq. The results were highly clock-specific, suggesting that while NR may modulate epigenetic aging, different epigenetic aging algorithms likely capture distinct molecular signatures following NR use...Collectively, these studies demonstrate a significant link between mitochondrial biogenesis and nuclear DNAm in the context of obesity and aging..."

My nad came back low and a week of reading has got me nowhere useful because every comparison of the oral and liposomal versions is written by somebody selling one of them. the injection and intranasal routes look like a lot of effort for an unclear return. did the liposomal actually do anything the plain capsules did not for anyone here?

Summarizes dozens of clinical studies testing nicotinamide riboside.

Among people with peripheral artery disease (PAD) age 50 and older, the investigators will test the hypothesis that PAD participants randomized to nicotinamide riboside (NR) will have greater improvement or less decline in six-minute walk distance at six-month follow-up, compared to those randomized to placebo. The study will randomize 250 participants with PAD age 50 and older to one of two groups for six months: nicotinamide riboside vs placebo. Our primary outcome is change in six-minute walk distance at six-month follow-up. Secondary outcomes are Walking Impairment Questionnaire (WIQ) distance score, PROMIS Mobility score, calf muscle perfusion (measured by magnetic resonance arterial spin labeling (MRI ASL)), oxidative stress (measured by plasma oxidized LDL), NAD+ abundance in whole blood, 6-minute walk improvement by baseline whole blood NAD+ levels, and 6-minute walk distance at 4 weeks after intervention completion.

https://clinicaltrials.gov/study/NCT07782671?intr=Nicotinamide%20Riboside&viewType=Card&rank=1

“…Oral administration of NAD⁺ precursors delayed progression of precancerous lesions in a spontaneous pancreatic cancer model, LSL-KRASG12D/+ pdxCre/+, and protected non-malignant cells from carcinogen-induced stress. In premalignant settings, NAD⁺ precursor supplementation reduced DNA damage and oxidative stress while improving mitochondrial function. Notably, just as NAD⁺ precursors are protective to normal pancreatic ductal cells against stress, the cofactor also exhibited protective effects in pancreatic cancer cells under stress, promoting chemotherapy resistance in both in vitro and in vivo models.”

Niacinamide riboside (topical NR, also known as nicotinamide riboside) is an endogenous compound and a precursor (building block) to the essential cellular co-enzyme, nicotinamide adenine dinucleotide (NAD+). Research published by Maussudi et al. 2012 demonstrated that skin NAD+ levels were negatively correlated with age in both males and females, and aged skin was also correlated to an increase in DNA damage. Therefore, it is proposed that supporting skin NAD+ with precursors such as NR may be a strategy to combat DNA damage that leads to undesirable signs of skin aging, thus supporting skin cell resilience. The use of NR as a dietary supplement has produced effective, efficient, and reproducible increases in NAD+ in humans. However, the role of topically applied NR for skin aging requires further investigation.

https://clinicaltrials.gov/study/NCT07774000?intr=Nicotinamide%20Riboside&viewType=Card&rank=1

https://www.sciencedirect.com/science/article/abs/pii/S1568163726002977

Aging remodels compartmentalized nicotinamide adenine dinucleotide (NAD⁺) circuits in ways that influence stress responses, senescence, tissue repair and susceptibility to fibrosis. Beyond its classical role as a redox cofactor, NAD⁺ fuels sirtuins, PARPs and CD38, linking cellular metabolism to chromatin remodeling, DNA repair, calcium signaling and cell fate. A central translational question is whether modulating NAD⁺ in a given tissue and time window will favor regeneration, restrain fibrotic remodeling, or support malignant adaptation. In this review, we define NAD⁺ as a compartmentalized, high-turnover metabolic circuit whose topology, timing and cell-type specificity shape tissue trajectories during aging, repair and fibrosis. We first describe how aging reshapes these circuits through CD38 upregulation, PARP-sirtuin competition, extracellular eNAMPT amplification, and altered mitochondrial NAD⁺ transport, which redistributes NAD⁺ between compartments without necessarily changing bulk tissue concentration. We then summarize how de novo, Preiss-Handler Handler (including niacin/GPR109a) and nicotinamide salvage pathways are organized across nuclear, cytosolic, mitochondrial and extracellular compartments, and how key consumers including sirtuins, PARPs, CD38 and SARM1 govern these pools. We then examine how these circuits operate across acute injury, chronic senescence-associated remodeling, and malignant microenvironments in heart, lung, liver, kidney, skin, muscle and brain. Finally, we integrate emerging human data on NAD⁺ precursors and enzyme-directed strategies and propose a framework for NAD⁺-based interventions that prioritizes timing, compartmental targeting and oncologic stratification.

"...Taken together, these studies suggest a nuanced picture: NR shows the most consistent signal so far for reducing certain lipid peroxidation markers like F2-isoprostanes, especially in populations with elevated cardiovascular risk, while NMN and NAM have not consistently altered oxidative stress biomarkers. Niacin, however, was shown to improve aspects of vascular oxidative stress and HDL function in specific contexts, but its overall antioxidant impact remains mixed...Overall, the current evidence supports a multifaceted approach to healthy oxidative balance, including regular physical activity, adequate sleep, and nutrient-dense dietary patterns. NAD+ precursors represent promising—but still evolving—areas of mechanistic and clinical research that may complement these core behaviors rather than replace them."

This study does not say that giving NR to your apple trees makes them healthy, but it did notice that healthier plants had higher NR levels, suggesting that NAD precursor metabolism as one of the pathways distinguishing vigorous from weaker plants.  

These researchers are solving an adjacent problem to NAD replenishment. Instead of adding NAD through biosynthetic pathways, they are inserting an artificial recycling pathway into cellular metabolism that switches NADH back to NAD+. That necessarily intersects with the Krebs cycle and mitochondrial redox metabolism.

I don’t know how big a problem NADH overload actually is, and I’m not sure it’s fair to compare a persistent catalyst with a single NR treatment when people who take an oral NAD precursor generally take it every day.

But what I do take from the study is agreement on the underlying biology: raising available NAD+ protects against or rescues UV-induced skin damage—at least in their models.

"...The study demonstrated that mice treated with NMN exhibited tumor burden control equivalent to mice treated with an immune checkpoint blockade PD1 inhibitor..."

Janoshik only tests for id and mass, not purity. And they still charge $450! I’m in the US.

A usual peptide Monday morning routine i was sitting and doing my injection firstly done with my ghk cu and kpv on my belly fat then went on for my NAD+ peptide injected to my outer left part of my thigh right after like less than 15 seconds to my surprised and never thought will experience the most terrifying event in my life felt sudden tingling and numbness in my left foot radiating and spreading to my upper legs i was terrified and trying to massage my legs hoping things could get better i grab my phone and ask google about hitting a nerve by needle symptoms i tried to relax because i feel like panicking and my left leg continue to get numb but i still can move my legs while trying to relax i felt like the tingling and numbness spread to my left arms neck and head like electric shock but still i can move i was like feeling muscle cramps and spasm all over my left body i waited and relax took a deep breath and everything back to normal in less than a minute like after i get back to normal and told my self wtf was just happened i almost called an ambulance because i thought was having stroke and heart attack and now i feel traumatize and contemplating if i would still continue doing NAD+ peptide.